Skip To Main Content
Arailym Abilbayeva on Muck Rack

Arailym Abilbayeva

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Arailym Abilbayeva’s profile

Articles by Arailym Abilbayeva

A deep-learning approach to predict mortality in very-low-birth-weight infants treated in the intensive care units using DeepSurv

|
By Nishankul Bozhbanbayeva, Arailym Abilbayeva, Anel Tarabayeva, Iskander Isgandarov, Dinara Yelyubayeva, Talgat Tolykbayev, Indira Adilbekova
| Frontiers
Abstract Background and objectives: Predicting mortality in very low-birth-weight (VLBW) infants remains a critical challenge in neonatology. While traditional scoring systems and standard machine learning models are widely used, they often fail to capture the complex, non-linear interactions and time-dependent dynamics of neonatal clinical courses.
Open in Who Shared Issue with article?

Integration of miRNA profiles and clinical data for early risk assessment of bronchopulmonary dysplasia in VLBW and ELBW newborn infants: a discovery study

|
By Iskander Isgandarov, Arailym Abilbayeva, Aibek Smagul, Anel Tarabayeva, Dinara Yelyubayeva, Nishankul Bozhbanbayeva, Ingkar Okhas, Nuray Shaktay, Dana Yerbolat, Kristina Kovaleva, Zhanar Akhmetova, Zulfiya Kachiyeva
| Frontiers
Abstract Background and objectives: Bronchopulmonary dysplasia (BPD) remains a significant complication linked to prematurity, especially in infants with very and extremely low birth weights. A major challenge in identifying prognostic biomarkers is the biological noise in blood samples, which masks the specific signals of BPD. This study aimed to identify candidate miRNA markers in the blood and develop integrated models for early BPD risk assessment.
Open in Who Shared Issue with article?

Correction: Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody–drug conjugates, and clinical trial innovations

|
By Gaukhar Koshkimbayeva, Akerke Amirkhanova, Aiken Orazymbetova, Alma Nurakhova, Akmaral Maimakova, Altyn Duisenbayeva, Nurgulim Akhmad, Altyn Abilova, Arailym Abilbayeva, Sholpan Akhelova, Dana Akhmentayeva, Aida M Seitaliyeva, Zaure Dushimova, Zhanserik Shynykul, Sandugash Yerkenova
| Frontiers
A Correction on Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody–drug conjugates, and clinical trial innovations By Koshkimbayeva G, Amirkhanova A, Orazymbetova A, Nurakhova A, Maimakova A, Duisenbayeva A, Akhmad N, Abilova A, Abilbayeva A, Akhelova S, Akhmentayeva D, Seitaliyeva A, Dushimova Z, Shynykul Z and Yerkenova S (2026) Front. Oncol. 15:1697180. doi: 10.3389/fonc.2025.1697180 Affiliation “Department of Anatomy named after S. R.
Open in Who Shared Issue with article?

Frontiers | Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody–drug conjugates, and clinical trial innovations

|
By Sholpan Akhelova, Aida M Seitaliyeva, Zhanserik Shynykul, Sandugash Yerkenova, Gaukhar Koshkimbayeva, Akerke Amirkhanova, Aiken Orazymbetova, Alma Nurakhova, Akmaral Maimakova, Altyn Duisenbayeva, Nurgulim Akhmad, Altyn Abilova, Arailym Abilbayeva, Dana Akhmentayeva, Zaure Dushimova
| Frontiers
1Department of General Medical Practice with Courses, Kazakh-Russian Medical University, Almaty, Kazakhstan 2School of Pharmacy, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan 3Department of Anatomy, Kazakhstan’s Medical University “KSPH”, Almaty, Kazakhstan 4Department of Normal Physiology with a course in Biophysics, School of Medicine, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan 5Clinical Medicine Department of International Business,...
Open in Who Shared Issue with article?
Show More